Imodium® has been delivering effective diarrhoea relief for over 50 years. So, it’s no wonder 85% of patients prefer Imodium® over other diarrhoea relief brands2.

 

Diarrhoea is a disruption of the digestive system caused by an imbalance of the physiological processes of the small and large intestine. This can result in loose or watery stools due to an increase in water content, and people can often experience abdominal pain, cramps and bloating too.

 

With Imodium®, your patients can get effective diarrhoea relief in just one hour. The active ingredient loperamide works in harmony with the body to help restore its natural rhythm and reduce water loss through diarrhoea.

 

Recommend Imodium® to your customers today – nothing works faster to relieve diarrhoea*.

 

 

Explore the Imodium® (loperamide) range

 

Imodium® is available in a variety of formats and sizes to suit your patients needs, whether that’s treatment for IBS diarrhoea or on-the-go relief. Discover more about the Imodium® range below.

Imodium® Dual Action

A unique formulation that provides multi-symptom relief from diarrhoea, bloating, wind and cramps. Suitable for patients experiencing both diarrhoea and abdominal discomfort.

 

View Dual Action range

Imodium ® Original

Can provide diarrhoea relief in just one dose. Imodium® Original is an ideal option for customers who want effective relief from their symptoms.
 

 

View Original range

Imodium® IBS Relief

An ideal choice for patients who have been medically diagnosed with Irritable Bowel Syndrome (IBS). The soft gel capsules are designed to relieve IBS diarrhoea.

 

View IBS Relief range

Imodium® Instants

Dissolve instantly on the tongue, with no need for water. Imodium® Instants can be taken anywhere, anytime – perfect for on-the-go relief or those who don’t like swallowing capsules.

 

View Instants range

How does Imodium work?

 

Loperamide is the key active ingredient in all Imodium® products. It acts directly on the opioid receptors on the intestinal wall, reducing peristalsis. This increases the transit time in the intestine, aiding the absorption of water and essential nutrients – leading to a normal stool consistency and frequency!

 

Imodium® Dual Action also contains an additional active ingredient, Simeticone. This helps reduce gas bubbles in the gut and alleviates other uncomfortable symptoms of diarrhoea, such as bloating, cramps and wind. And with people experiencing at least one of these additional symptoms on 62% of diarrhoea occasions in the UK, the Dual Active formula can be a beneficial option for many.

 

IMODIUM® (loperamide) discussion guide

Download the Imodium® discussion guide to learn which Imodium® products to recommend to your patients and customers.

 

Imodium discussion guide highlight banner


 

Why recommend Imodium® to your patients?

 

 

 

No.1 best-selling diarrhoea relief brand in the UK¹

 

 

 

 

Delivering effective diarrhoea relief for over 50 years

 

 

 

 

Diarrhoea relief within 1 hour

 

 


 

 

Patients recover from diarrhoea up to 3x faster with Imodium*

 

 

 

 

96% of patients recommend Imodium for fast relief within one hour3

 

 

 

*Median time to last unformed stool vs placebo

 

Click here for Imodium® (loperamide) Product Information

Want to learn more about diarrhoea?

 

Expert Video

Myth-Busting - Diarrhoea should be left to run its course? - Imodium (loperamide)

Learn more
 

Expert Video

Myth busting: Imodium (loperamide) and constipation

Learn more
 

Expert Video

Myth-busting loperamide is only for severe acute diarrhoea

Learn more

Find more Imodium® resources

 

Patient Tool

IMODIUM® range guide

Learn more

 

References

 

1. Source© NielsenIQ data, Value, Units, anti-diarrhoea category (client defined) 52 w/e 02.12.2023 (GB Total Coverage).

2. July 2022 survey of 156 frequent diarrhoea sufferers.

3. July 2022 survey of 304 frequent & occasional diarrhoea suffers.

 

*For claims verification, please call 0808 238 9999.

Click here for Imodium® (loperamide) Product Information

 

Date of preparation: December 2023

UK-ACA-2300478